25 studies found for:    " July 11, 2012":" August 10, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" July 11, 2012":" August 10, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects
Conditions: Hepatitis C,;   Human Immunodeficiency Virus
Interventions: Drug: Sofosbuvir;   Drug: RBV
2 Active, not recruiting Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
Conditions: HIV;   HIV Infections;   AIDS;   Antiretroviral Therapy
Interventions: Behavioral: Control;   Behavioral: Intervention
3 Recruiting Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program
Condition: Human Immunodeficiency Virus Infection
Intervention:
4 Completed Relative Bioavailability Study of GSK1265744 Formulations
Condition: Infections, Human Immunodeficiency Virus and Hepatitis
Interventions: Drug: GSK1265744 Na Salt Tablets;   Drug: GSK1265744 Free Acid Nanomilled Capsules;   Drug: GSK1265744 Free Acid Micronized Capsules
5 Active, not recruiting BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection
Condition: HIV
Intervention: Drug: efavirenz
6 Unknown  EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Conditions: HIV;   Tuberculosis
Intervention: Drug: Rifabutin
7 Recruiting Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination
Conditions: Tuberculosis;   HIV
Interventions: Biological: MVA85A;   Biological: Candin;   Biological: BCG Vaccine SSI
8 Recruiting Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease
Conditions: HIV;   Hepatitis C
Intervention: Drug: Rifaximin
9 Recruiting Clinical Outcomes in Persons With HIV Acquired Early in Life
Conditions: HIV;   Childhood;   Natural History;   Cardiac;   ART
Intervention:
10 Recruiting An Interactive Game for HIV Prevention in Early Adolescents
Conditions: HIV;   Risk Reduction
Interventions: Behavioral: Experimental Video Game;   Behavioral: Off the Shelf Video Game
11 Unknown  A Couple-Based Relationship Strengthening HIV Intervention for Young Parents
Condition: HIV
Interventions: Behavioral: Relationship Strengthening HIV Prevention Intervention;   Behavioral: Parenting Program Intervention
12 Not yet recruiting Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV
Conditions: Anal Dysplasia;   Human Papilloma Virus;   HIV
Interventions: Drug: imiquimod;   Procedure: ablative
13 Completed Atazavanir/Ritonavir-based HAART in Children
Condition: HIV
Intervention: Drug: boosted atazanavir (ATV/r)
14 Recruiting Abacavir and Lamivudine PK in Children
Condition: HIV
Interventions: Drug: abacavir;   Drug: 3TC
15 Completed Vitamin D Supplementation in HIV-infected Youth
Conditions: HIV Disease;   Vitamin D Deficiency;   Hypovitaminosis D;   Hyperparathyroidism
Interventions: Drug: oral cholecalciferol 1000000 UI (vitamin D3);   Drug: Placebo
16 Completed Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults
Condition: HIV-1 Infection in Adults
Intervention: Drug: Antibody UB-421
17 Active, not recruiting Children With HIV and Asthma (CHIVAS)
Condition: T Cell Response to Asthma in HIV-infected Patients Before and After Starting Treatment
Intervention: Drug: HAART
18 Completed Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
Conditions: Opioid Dependence;   Hepatitis;   HIV
Interventions: Other: computerized Cognitive Behavioral Therapy (CBT);   Other: Treatment as Usual (TAU)
19 Completed Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth
Conditions: HIV;   Pregnancy;   Malnutrition;   Cachexia
Intervention:
20 Active, not recruiting Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine
Condition: HIV
Interventions: Drug: Tenofovir (TFV) Alone Vaginal Tablet;   Drug: Emtricitabine (FTC) Alone Vaginal Tablet;   Drug: TFV and FTC Combined Vaginal Tablet;   Drug: Placebo Vaginal Tablet

Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results
Indicates status has not been verified in more than two years